Overview
Most metabolic-research compounds in this catalog are incretin-system agonists (GLP-1, GIP, and glucagon-receptor ligands) and related signaling molecules. The published literature studies them for metabolic and body-composition research endpoints. This guide describes how the compound is characterized and what that research covers. It is not usage guidance and makes no claim about outcomes from use.
A 33-amino-acid peptide studied for intestinal epithelial growth and barrier-function research.
Evidence at a glance: Preclinical (animal) evidence
The cited evidence here is preclinical animal-model work, with limited or no human-trial data. Read the research profile accordingly.
Molecular identity
- Molecular formula
- C164H252N44O52
- Molecular weight
- 3766.2 g/mol
- CAS number
- 223460-79-9
- Amino acids
- 33
- Appearance
- White lyophilized powder
- Purity (HPLC)
- 98.7%
Researched mechanism
GLP-2 receptor agonism, studied for trophic effects on intestinal mucosa.
Described as a mechanism characterized in the literature, not an effect you should expect from use.
What the published research shows
Intestinal trophic effects characterized in preclinical models.
Every citation states its study type and population, so preclinical data is never presented as human-efficacy evidence.
How it compares
| Versus | Attribute | Note |
|---|---|---|
| BPC-157 | Research area | Both appear in gut-research contexts by different mechanisms. |
Reconstitution
Concentration math only: adding bacteriostatic water to the vial gives the resulting mg/mL shown below. This is not usage guidance.
| Vial | Bacteriostatic water | Concentration |
|---|---|---|
| 5 mg | 2 mL | 2.5 mg/mL |
| 10 mg | 2 mL | 5 mg/mL |
Storage & stability
| State | Temperature | Duration |
|---|---|---|
| Lyophilized (unopened) | -20°C | 24 months |
| Reconstituted | 2–8°C | up to 3 weeks |
Common questions
What research area is this used in?+
Primarily intestinal-biology research; see the cited literature.
